glp-1 news october 16 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo Perspectives from employers on the
Description
GIP (Glucose-Dependent Insulinotropic Polypeptide) receptor agonist This hormone improves how the body processes fat and enhances the effects of GLP-1, further suppressing appetite and promoting fat loss
showed that liraglutide downregulates expression of the fibrosis markers TGF-1 and collagen types I and III, which might explain, at least in part, how GLP-1RAs reduce cardiac fibrosis in heart failure models (44)
These agents are integral in clinical practice to improve cardiovascular outcomes in patients with diabetes
The insulinotropic effects of GIPR and GLP-1R agonism effectively neutralize the glucose-elevating potential of GCGR activation
